Related Experiment Video
Updated: Jun 10, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Non-polypoid colorectal neoplasms in ulcerative colitis.
Yoshitaka Ueno1, Shinji Tanaka, Kazuaki Chayama
1Department of Endoscopy, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. yueno@hiroshima-u.ac.jp
Gastrointestinal Endoscopy Clinics of North America
|July 27, 2010
Summary
Early detection of colorectal cancer in ulcerative colitis (UC) is crucial. Advanced endoscopic techniques like magnifying chromoendoscopy aid in identifying subtle lesions, potentially replacing random biopsies for better patient outcomes.
Area of Science:
- Gastroenterology
- Endoscopy
- Oncology
Background:
- Colorectal cancer (CRC) incidence rises with duration of ulcerative colitis (UC).
- Identifying dysplasia-associated lesions or masses (DALM) and non-polypoid colorectal neoplasms (NP-CRN) is vital for reducing CRC morbidity and mortality in UC patients.
- Most dysplastic lesions in UC are now considered visible during careful endoscopic examination.
Purpose of the Study:
- To highlight the importance of detecting subtle neoplastic lesions in UC patients.
- To introduce magnifying chromoendoscopy as a tool for diagnosing NP-CRN in UC.
- To advocate for the shift from random to targeted biopsies in UC surveillance.
Main Methods:
- Review of recent findings on endoscopic detection of neoplastic lesions in UC.
- Emphasis on careful mucosal examination and noting subtle differences.
- Application of magnifying chromoendoscopy for enhanced visualization and diagnosis.
Main Results:
- Subtle mucosal differences are key to identifying NP-CRN in UC.
- Magnifying chromoendoscopy improves the endoscopic diagnosis of subtle findings.
- Targeted biopsies during chromoendoscopy show promise in UC surveillance.
Conclusions:
- Early and accurate detection of neoplastic lesions in UC is essential.
- Magnifying chromoendoscopy is a valuable tool for diagnosing subtle findings in UC.
- Targeted biopsies are likely to supersede random biopsies in future UC surveillance strategies.
More Related Videos
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...